Rowland & CO Investment Counsel Baxter International Inc Transaction History

Rowland & CO Investment Counsel

  • $486 Million
  • Q3 2024

A detailed history of Rowland & CO Investment Counsel transactions in Baxter International Inc stock. As of the latest transaction made, Rowland & CO Investment Counsel holds 5,680 shares of BAX stock, worth $203,343. This represents 0.04% of its overall portfolio holdings.

Number of Shares
5,680
Previous 5,679 0.02%
Holding current value
$203,343
Previous $189,000 13.76%
% of portfolio
0.04%
Previous 0.04%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024
BUY
$32.85 - $40.26 $32 - $40
1 Added 0.02%
5,680 $215,000
Q2 2024

Jul 29, 2024
SELL
$32.87 - $43.55 $23,633 - $31,312
-719 Reduced 11.24%
5,679 $189,000
Q1 2024

Apr 08, 2024
SELL
$37.88 - $43.77 $11,477 - $13,262
-303 Reduced 4.52%
6,398 $273,000
Q4 2023

Jan 03, 2024
BUY
$31.71 - $38.95 $63 - $77
2 Added 0.03%
6,701 $259,000
Q3 2023

Oct 26, 2023
SELL
$37.32 - $49.29 $12,763 - $16,857
-342 Reduced 4.86%
6,699 $252,000
Q2 2023

Aug 04, 2023
BUY
$39.98 - $47.68 $39 - $47
1 Added 0.01%
7,041 $320,000
Q1 2023

Apr 25, 2023
BUY
$37.58 - $52.57 $44,006 - $61,559
1,171 Added 19.95%
7,040 $285,000
Q4 2022

Jan 04, 2023
BUY
$49.7 - $57.71 $49 - $57
1 Added 0.02%
5,869 $0
Q3 2022

Oct 06, 2022
BUY
$53.86 - $66.8 $161 - $200
3 Added 0.05%
5,868 $316,000
Q2 2022

Aug 15, 2022
BUY
$63.83 - $80.0 $27,191 - $34,080
426 Added 7.83%
5,865 $376,000
Q1 2022

Apr 26, 2022
SELL
$76.85 - $89.45 $8,991 - $10,465
-117 Reduced 2.11%
5,439 $421,000
Q4 2021

Feb 14, 2022
SELL
$74.57 - $87.19 $98,283 - $114,916
-1,318 Reduced 19.17%
5,556 $476,000
Q3 2021

Nov 08, 2021
BUY
$73.77 - $83.61 $100,474 - $113,876
1,362 Added 24.71%
6,874 $552,000
Q1 2021

May 11, 2021
SELL
$76.38 - $86.03 $102,654 - $115,624
-1,344 Reduced 19.6%
5,512 $464,000
Q4 2020

Feb 11, 2021
SELL
$75.39 - $82.36 $1,281 - $1,400
-17 Reduced 0.25%
6,856 $550,000
Q3 2020

Nov 12, 2020
SELL
$78.33 - $90.73 $78 - $90
-1 Reduced 0.01%
6,873 $552,000
Q2 2020

Aug 10, 2020
BUY
$78.66 - $94.14 $78 - $94
1 Added 0.01%
6,874 $591,000
Q1 2020

May 11, 2020
SELL
$71.57 - $93.3 $5,868 - $7,650
-82 Reduced 1.18%
6,873 $558,000
Q4 2019

Jan 28, 2020
BUY
$76.7 - $88.45 $76 - $88
1 Added 0.01%
6,955 $581,000
Q3 2019

Oct 02, 2019
SELL
$81.4 - $89.78 $34,595 - $38,156
-425 Reduced 5.76%
6,954 $608,000
Q4 2018

Feb 12, 2019
BUY
$61.45 - $77.8 $15,362 - $19,450
250 Added 3.51%
7,379 $485,000
Q4 2017

Jan 11, 2018
BUY
$61.45 - $66.05 $297,172 - $319,417
4,836 Added 210.9%
7,129 $0
Q3 2017

Oct 11, 2017
SELL
$59.5 - $64.61 $298,154 - $323,760
-5,011 Reduced 68.61%
2,293 $0
Q3 2017

Oct 11, 2017
BUY
$59.5 - $64.61 $434,588 - $471,911
7,304
7,304 $0

Others Institutions Holding BAX

# of Institutions
998
Shares Held
449M
Call Options Held
2.22M
Put Options Held
3.04M
View Full List

About BAXTER INTERNATIONAL INC

BAX Quotes by TradingView
  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $18B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Rowland & CO Investment Counsel Portfolio

Follow Rowland & CO Investment Counsel and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rowland & CO Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Rowland & CO Investment Counsel with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email